【导读】控股股东筹划控制权变更，河化股份明日起停牌 7月30日晚间，河化股份发布公告称，公司收到控股股东宁波银亿控股有限公司的通知，其正在筹划股权转让相关事宜，该事项可能导致公司控股股东及 实际控制人发生变更。目前各方尚未签署正式交易协议，拟就相关事项进行进一步论证和磋商。 根据公告，该基金主要投资于原料药企业上下游、合成生物医药等行业领域优质股权标的企业，或全体合伙人认可的其他未上市企业股权。投资期为3 年，退出期为2年。 河化股份表示，此次投资旨在优化公司资金使用效率，借助专业机构资源把握市场机会，但对基金可能面临的政策、市场等风险需保持关注。本次投资资 金来源于公司自有资金，不会对财务状况和经营成果产生重大影响。 公开资料显示，河化股份主要从事医药中间体的研发、生产与销售业务以及尿素委托加工销售业务。 值得注意的是，7月30日，河化股份股价盘中异动拉升，快速涨停。截至收盘，河化股份股价报8.02元/股，总市值为29亿元。 （文章来源：中国基金报） 河化股份表示，鉴于该事项正在筹划中，具有较大不确定性。为保证公平信息披露，维护投资者利益，避免造成公司股价异常波动，公司股票自7月31日 上午开市起停牌，预计 ...

Core Viewpoint - The controlling shareholder of Hehua Co., Ltd. is planning a change in control, leading to a temporary suspension of the company's stock trading starting July 31 [1][3]. Group 1: Shareholder Control Change - Hehua Co., Ltd. announced that its controlling shareholder, Ningbo Yinyi Holdings Co., Ltd., is in the process of planning a share transfer, which may result in a change of the controlling shareholder and actual controller [1]. - No formal transaction agreements have been signed yet, and further discussions and evaluations are ongoing regarding this matter [1]. Group 2: Stock Suspension - Due to the ongoing planning of the shareholder control change, Hehua Co., Ltd. has decided to suspend its stock trading to ensure fair information disclosure and protect investor interests, with the suspension expected to last no more than two trading days [3]. Group 3: Investment Activities - Recently, Hehua Co., Ltd. has been active in investment, announcing on July 11 that it will invest 5 million yuan in establishing a venture capital fund in partnership with a professional investment institution and an individual [3]. - The total initial capital commitment for the fund is 11 million yuan, with Hehua Co., Ltd. holding a 45.45% stake [3]. - The fund will primarily invest in high-quality equity targets in the upstream and downstream of raw pharmaceutical enterprises and synthetic biological medicine, with an investment period of three years and an exit period of two years [3]. Group 4: Company Profile - Hehua Co., Ltd. is primarily engaged in the research, development, production, and sales of pharmaceutical intermediates, as well as the commissioned processing and sales of urea [4]. - On July 30, Hehua Co., Ltd. experienced a significant stock price increase, reaching a closing price of 8.02 yuan per share, with a total market capitalization of 2.9 billion yuan [4].

Group 1 - The core viewpoint of the article is that Hehua Co., Ltd. is undergoing a potential change in control due to its major shareholder, Ningbo Yinyi Holdings Co., Ltd., planning a share transfer, which may lead to a change in the company's controlling shareholder and actual controller [2][3] - Hehua Co., Ltd. announced a stock suspension starting from July 31 to ensure fair information disclosure and protect investor interests, with the suspension expected to last no more than two trading days [3] - The company is participating in the establishment of a venture capital fund with a total initial investment of 1.1 million yuan, where Hehua Co., Ltd. will contribute 500,000 yuan, accounting for 45.45% of the total [4][5] Group 2 - The venture capital fund will primarily invest in high-quality equity targets in the upstream and downstream of raw pharmaceutical enterprises and synthetic biological medicine, with an investment period of three years and an exit period of two years [5] - Hehua Co., Ltd. is engaged in the research, production, and sales of pharmaceutical intermediates and urea processing and sales [5] - On July 30, Hehua Co., Ltd.'s stock price experienced significant movement, reaching a closing price of 8.02 yuan per share, with a total market capitalization of 2.9 billion yuan [5]

中国经济网北京7月30日讯河化股份（000953.SZ）今日涨停，收报8.02元，涨幅10.01%。 （责任编辑：徐自立） 鉴于该事项正在筹划中，具有较大不确定性。为保证公平信息披露，维护投资者利益，避免造成公司股 价异常波动，根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第6号 ——停复牌》等有关规定，经公司向深圳证券交易所申请，公司股票（股票简称：河化股份，股票代 码：000953）自2025年7月31日（星期四）上午开市起停牌，预计停牌时间不超过2个交易日。 河化股份今晚发布关于筹划公司控制权变更事项的停牌公告。公司近日收到控股股东宁波银亿控股有限 公司的通知，其正在筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目 前各方尚未签署相关正式交易协议，拟就相关事项进行进一步论证和磋商，具体情况以各方签订的相关 正式交易协议为准。 ...

（原标题：7月30日重要资讯一览） 重要的消息有哪些 1．中共中央政治局7月30日召开会议，会议指出，要持续防范化解重点领域风险。落实好中央城市工作会议精神，高质量开展城市更新。积极稳 妥化解地方政府债务风险，严禁新增隐性债务，有力有序有效推进地方融资平台出清。增强国内资本市场的吸引力和包容性，巩固资本市场回稳 向好势头。 2．财政部社会保障司司长郭阳7月30日在国新办新闻发布会上表示，中央财政将设立共同财政事权转移支付项目"育儿补贴补助资金"，今年初步 安排预算900亿元左右。对于发放国家基础标准补贴所需资金，中央财政按照一定比例对地方予以补助，中央财政总体承担90%。 3．7月30日，外交部发言人郭嘉昆主持例行记者会。在回答有关中美经贸会谈的问题时，郭嘉昆表示，关于此次中美经贸会谈的情况，中方已经 发布了消息。我们希望美方同中方一道，按照两国元首通话达成的重要共识，发挥好中美经贸磋商机制的作用，在平等、尊重、互惠基础上，通 过对话沟通，增进共识、减少误解、加强合作，争取更多双赢成果，共同推动中美关系健康稳定可持续发展。 4．国家发改委向社会公开征求《政府投资基金布局规划和投向工作指引》和《加强政府投资基金 ...

Important Announcements - Company Shouwei New Materials will suspend trading for inspection on July 31, 2025, due to abnormal stock price fluctuations from July 9 to July 30, 2025 [2] - Company XGIMI Technology expects a net profit attributable to shareholders of 88.66 million yuan for the first half of the year, a year-on-year increase of 2062.33% [4] - Company Yuntian Lifei has submitted an application for H-share issuance and listing [5] - Company Huaheng Biological is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Company Hehua Co., Ltd. is planning a change in control, leading to a suspension of trading [10] Financial Performance - Company Dingtong Technology reported a net profit of 115 million yuan for the first half of the year, a year-on-year increase of 134.06%, with a proposed cash dividend of 2 yuan per 10 shares [7] - Company Jinhai Biological achieved a net profit of 138 million yuan in the first half of the year, a year-on-year increase of 51.52% [13] - Company Hisense Home Appliances reported a net profit of 2.077 billion yuan for the first half of the year, a year-on-year increase of 3.01% [14] Corporate Actions - Company Nanxin Pharmaceutical is planning to acquire a domestic pharmaceutical technology asset group, but there is significant uncertainty regarding the completion of this acquisition [3] - Company Jinchengzi is planning to acquire 55% of the shares of Changchun Samit Optoelectronics Technology Co., Ltd., leading to a suspension of trading [9] - Company San Chao New Materials is also planning a change in control, resulting in a trading suspension [11] Project Investments - Company Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project [8]

7月30日晚间，河化股份（000953）公告，公司近日收到控股股东宁波银亿控股有限公司的通知，其正 在筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目前各方尚未签署相 关正式交易协议，拟就相关事项进行进一步论证和磋商，具体情况以各方签订的相关正式交易协议为 准。 公告显示，鉴于该事项正在筹划中，具有较大不确定性。为保证公平信息披露，维护投资者利益，避免 造成河化股份股价异常波动，根据深交所有关规定，经公司向深圳证券交易所申请，公司股票自2025年 7月31日上午开市起停牌，预计停牌时间不超过2个交易日。 河化股份还提到，公司将继续加大对主营业务企业南松医药战略转型的支持力度，充分调动一切资源， 为企业产品开发和市场拓展提供帮助。同时，克服尿素市场行情波动大，公司尿素品牌效应降低的不利 因素影响，继续开展尿素委托加工及销售业务，维护"群山"品牌和经销商网络。此外，公司将进一步健 全安全消防环保管理体系，牢固树立安全无小事理念，定期组织开展安全、消防、环保等各类培训，加 强监督管理，有效杜绝生产安全事故的发生。 截至今年一季度末的数据显示，河化股份第一大股东为宁波银亿控股有限公司，持股比例 ...

Group 1: Company Announcements - Upwind New Materials will suspend trading for stock review starting July 31, 2025, due to abnormal price fluctuations from July 9 to July 30, 2025 [2] - XGIMI Technology expects a net profit attributable to shareholders of 88.66 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [4] - CloudWalk Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [5] - Huaheng Biological is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Hehua Co., Ltd. is undergoing a control change process, leading to a stock suspension starting July 31, 2025 [9] Group 2: Financial Performance - DingTong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06%, with a proposed cash dividend of 2 yuan per 10 shares [7] - Jinhe Biological achieved a net profit of 138 million yuan in the first half of 2025, a year-on-year increase of 51.52% [12] - Hisense Home Appliances reported a net profit of 2.077 billion yuan for the first half of 2025, a year-on-year increase of 3.01% [13] Group 3: Corporate Developments - Nanxin Pharmaceutical is planning to acquire a domestic pharmaceutical technology asset group, but there is significant uncertainty regarding the completion of this acquisition [3] - Jinchengzi is planning to acquire 55% of the equity of Changchun Samit Optoelectronics Technology Co., Ltd., leading to a stock suspension starting July 31, 2025 [8] - SanChao New Materials is also planning a control change, resulting in a stock suspension starting July 31, 2025 [10] Group 4: Industry Developments - Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project, with a total construction period of 91 months [8] - Yonghui Supermarket intends to raise no more than 3.992 billion yuan through a private placement to upgrade stores and logistics [8]

公司股票自2025年7月31日(星期四)上午开市起停牌，预计停牌时间不超过2个交易日。 智通财经APP讯，河化股份(000953.SZ)公告，公司近日收到控股股东宁波银亿控股有限公司的通知，其 正在筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目前各方尚未签署 相关正式交易协议，拟就相关事项进行进一步论证和磋商。 ...

河化股份（000953）(000953.SZ)公告，公司近日收到控股股东宁波银亿控股有限公司的通知，其正在 筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目前各方尚未签署相关 正式交易协议，拟就相关事项进行进一步论证和磋商。 公司股票自2025年7月31日(星期四)上午开市起停牌，预计停牌时间不超过2个交易日。 ...